Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MD

Michael P. Dwyer — 51 Patents

SCSchering: 36 patents #45 of 2,442Top 2%
Merck: 15 patents #713 of 9,382Top 8%
PDPharmacopeia Drug Discovery: 11 patents #3 of 193Top 2%
PHPharmacopeia: 3 patents #65 of 211Top 35%
MCMochida Pharmaceutical Co.: 1 patents #173 of 309Top 60%
MCMsd R&D (China) Co.: 1 patents #32 of 80Top 40%
Scotch Plains, NJ: #4 of 466 inventorsTop 1%
New Jersey: #879 of 69,400 inventorsTop 2%
Overall (All Time): #51,932 of 4,157,543Top 2%
51 Patents All Time
Michael P. Dwyer has been granted 51 US patents while listed as an inventor at Schering. The first was granted in 2005 and the most recent in May 2020. Michael P. Dwyer ranks #51,932 of 4,157,543 US inventors in our database (top 1.2%). Patent records list Michael P. Dwyer in Scotch Plains, NJ, US.

Issued Patents All Time

Showing 1–25 of 51 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10646494 Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases Wensheng Yu, Ling Tong, Joseph A. Kozlowski, Craig A. Coburn, De-Yi Yang +7 more 2020-05-12 $155,382,000
10357481 Substituted triazolo bicyclic compounds as PDE2 inhibitors Gregori J. Morriello, Lehua Chang, Ashley Forster, Yili Chen, Zack Zhiqiang Guo +4 more 2019-07-23 $139,741,000
10287293 Bicyclic heterocyclic compounds as PDE2 inhibitors Shawn J. Stachel, Christopher Joseph Sinz, Jonathan E. Wilson, Daniel V. Paone, Yili Chen +1 more 2019-05-14 $81,943,000
10174037 Dihydropyrazolopyrimidinone compounds as PDE2 inhibitors Dong-Ming Shen, Christopher Joseph Sinz, Deping Wang, Shawn J. Stachel, Daniel V. Paone +6 more 2019-01-08 $185,104,000
10160762 6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors Dong-Ming Shen, Christopher Joseph Sinz, Deping Wang, Shawn J. Stachel, Daniel V. Paone +11 more 2018-12-25
10138255 Piperazine derivatives as HIV protease inhibitors Peter D. Williams, John A. McCauley, Christopher James Bungard, David Jonathan Bennett, Sherman T. Waddell +13 more 2018-11-27 $94,550,000
9840478 Piperazine derivatives as HIV protease inhibitors Peter D. Williams, John A. McCauley, David Jonathan Bennett, Christopher James Bungard, Lehua Chang +17 more 2017-12-12 $85,898,000
9254292 Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases Craig A. Coburn, Brian J. Lavey, Joseph A. Kozlowski, Stuart B. Rosenblum 2016-02-09 $262,061,000
8987242 Morpholinone compounds as factor IXA inhibitors Samuel Chackalamannil, Tin-Yau Chan, Mariappan V. Chelliah, Martin C. Clasby, William J. Greenlee +6 more 2015-03-24 $65,013,000
8673924 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors Timothy J. Guzi, Kamil Paruch, Ronald J. Doll, Viyyoor M. Girijavallabhan, Alan K. Mallams +15 more 2014-03-18 $46,244,000
8642582 Morpholinone compounds as factor IXa inhibitors Hidemitsu Nishida, Fumihiko Saitoh, Tomokazu Hirabayashi, Samuel Chackalamannil, Tin-Yau Chan +4 more 2014-02-04 $91,639,000
8609676 4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors Mariappan V. Chelliah, Samuel Chackalamannil, William J. Greenlee, Keith Eagan, Zhuyan Guo +6 more 2013-12-17 $54,459,000
8586576 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors Timothy J. Guzi, Kamil Paruch, Marc A. Labroli, Kartik M. Keertikar 2013-11-19 $50,784,000
8580782 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors Timothy J. Guzi, Kamil Paruch, Marc A. Labroli, Kartik M. Keertikar 2013-11-12 $66,896,000
8318735 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors Gerald W. Shipps, Jr., Cliff C. Cheng, Xiaohua Huang, Thierry Olivier Fischmann, Jose S. Duca +12 more 2012-11-27 $59,805,000
8211854 Methods for inhibiting protein kinases Timothy J. Guzi, Kamil Paruch, David A. Parry 2012-07-03
8207221 Crystalline polymorphs of a CXC-chemokine receptor ligand Mengwei Hu, Younong Yu, Arthur G. Taveras, Agnes S. Kim-Meade, Jianguo Yin +4 more 2012-06-26
7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Arthur G. Taveras, Cynthia Aki, Richard Bond, Jianping Chao, Johan Ferreira +10 more 2011-06-21
7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Arthur G. Taveras, Cynthia Aki, Richard Bond, Jianping Chao, Johan Ferreira +9 more 2011-05-24
7807683 N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors Timothy J. Guzi, Kamil Paruch, Ronald J. Doll, Viyyoor M. Girijavallabhan, Alan K. Mallams +13 more 2010-10-05
7776865 Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors Kamil Paruch, Timothy J. Guzi, Carmen Alvarez 2010-08-17
7645762 Substituted pyrazolo[1,5-a] pyrimidines as protein kinase inhibitors Kamil Paruch, Timothy J. Guzi 2010-01-12
7642266 Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors Timothy J. Guzi, Kamil Paruch 2010-01-05
7605155 Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors Timothy J. Guzi, Kamil Paruch, Marc A. Labroli, Kartik M. Keertikar 2009-10-20 $142,962,000
7601724 Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors Timothy J. Guzi, Kamil Paruch 2009-10-13 $143,977,000